Fresenius Medical Care AG & Co. (FMS)
(Real Time Quote from BATS)
$22.59 USD
+0.61 (2.78%)
Updated May 15, 2024 11:52 AM ET
4-Sell of 5 4
A Value C Growth D Momentum B VGM
Brokerage Reports
Fresenius Medical Care AG & Co. KGaA [FMS]
Reports for Purchase
Showing records 101 - 120 ( 141 total )
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Discontinuation of Research Coverage
Provider: FELTL & COMPANY
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Inline 4Q13 results; 2014 guidance fails to impress as margin pressure increases
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
CMS finalized dialysis rebasing with a four year phase-in period
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
3Q13 largely inline with expectations; rebasing overhang continues
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Fireworks start early as CMS proposed ESRD rule worse than expected
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: Fresenius Medical Care AG & Co. KGaA
Industry: Medical - Instruments
Weak 1Q13 results; we see no reason to step in, maintain HOLD
Provider: FELTL & COMPANY
Analyst: WEIGHT M